0001209191-23-011047.txt : 20230221 0001209191-23-011047.hdr.sgml : 20230221 20230221123845 ACCESSION NUMBER: 0001209191-23-011047 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230216 FILED AS OF DATE: 20230221 DATE AS OF CHANGE: 20230221 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kashmolah Ghazi CENTRAL INDEX KEY: 0001877741 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39976 FILM NUMBER: 23646724 MAIL ADDRESS: STREET 1: 1412 62ND STREET CITY: EMERYVILLE STATE: CA ZIP: 94608 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Lucira Health, Inc. CENTRAL INDEX KEY: 0001652724 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 272491037 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1315 63RD STREET CITY: EMERYVILLE STATE: CA ZIP: 94608 BUSINESS PHONE: (814) 574-1546 MAIL ADDRESS: STREET 1: 1315 63RD STREET CITY: EMERYVILLE STATE: CA ZIP: 94608 FORMER COMPANY: FORMER CONFORMED NAME: DiAssess Inc. DATE OF NAME CHANGE: 20150908 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2023-02-16 1 0001652724 Lucira Health, Inc. LHDX 0001877741 Kashmolah Ghazi 1412 62ND STREET EMERYVILLE CA 94608 0 1 0 0 Ex VP & Chief Quality Officer Common Stock 2023-02-16 4 S 0 5028 0.27 D 134075 D These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units granted on September 30,2021 for 197,240 shares. /s/ Richard Narido, Attorney-in-Fact for Ghazi Kashmolah 2023-02-21